Providence research from Northern California locations.

Follow

Submissions from 2023

Link

ACR-ARS Practice Parameter for Radiation Oncology., Simon Lo, Samuel Chao, Eleanor Harris, Jonathan Knisely, Join Y Luh, Pranshu Mohindra, Tony S Quang, Jason Ye, William Small, and Naomi R Schechter

Link

Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide., YaoYao Pollock, Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, David Olmos, Ji Youl Lee, Hiroji Uemura, Amitabha Bhaumik, Anil Londhe, Brendan Rooney, Sabine D Brookman-May, Peter De Porre, Suneel D Mundle, and Eric J Small

Link

BRIDGING THE GAP BETWEEN VOLUME AND QUALITY IN MULTIARTERIAL GRAFTING., Dominic C Regli, Mark E Pridmore, H Alden Book, Eric J Kuttler, and Joseph M Arcidi

Submissions from 2022

Link

Prehospital triage tools across the world: a scoping review of the published literature., Smitha Bhaumik, Merhej Hannun, Chelsea Dymond, Kristen DeSanto, Whitney Barrett, Lee A Wallis, and Nee-Kofi Mould-Millman

Link

A two-dimensional discrete delay-differential system model of viremia, Joseph E. Carroll

Link

A two-dimensional discrete delay-differential system model of viremia., Joseph E. Carroll

Link

The Economic Impact of Lower Extremity Peri-Prosthetic Fractures in a Large Hospital System., James P Crutcher, Geoffrey Tompkins, Genevieve Rollier, Katie Sypher, Rebecca Valderrama, and Paul J Duwelius

Open-label, phase 2, multicenter study of lasofoxifene (LAS) combined with abemaciclib (Abema) for treating pre- and postmenopausal women with locally advanced or metastatic ER+/HER2− breast cancer and an ESR1 mutation after progression on prior therapies., Senthil Damodaran, Paul V. Plourde, Halle CF Moore, Ian Churchill Anderson, and David Jay Portman

Link

ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update., Expert Panel on Interventional Radiology, Erica M Knavel Koepsel, Amanda R Smolock, Jason W Pinchot, Charles Y Kim, Osmanuddin Ahmed, Murthy R K Chamarthy, Elizabeth M Hecht, Gloria L Hwang, David E Kaplan, Join Y Luh, Jorge A Marrero, Eric J Monroe, George A Poultsides, Matthew J Scheidt, and Eric J Hohenwalter

Link

A Randomized Pilot Study Assessing if SEDLine Monitoring During Induction of Surgical Patients is Associated With Reduced Dosage of Administered Induction Agents., Martin Krause, Albert Nguyen, Orestes O'Brien, Swapnil Khoche, and Ulrich Schmidt

Link

Surgical Site Infection in Thoracic Surgery Is Not Associated With Perioperative Hypothermia., Albert P Nguyen, Minh Tran, Swapnil Khoche, Rodney A Gabriel, and Ulrich Schmidt

Link

Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide., YaoYao Pollock, Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, David Olmos, Ji Youl Lee, Hiroji Uemura, Amitabha Bhaumik, Anil Londhe, Brendan Rooney, Sabine D Brookman-May, Peter De Porre, Suneel D Mundle, and Eric J Small

Link

Phenobarbital and/or benzodiazepines for recurrent alcohol withdrawal: A self-controlled, retrospective cohort study., Alex Staidle and Curtis Geier

Submissions from 2021

Link

Leveling the Playing Field: Accounting for Academic Productivity During the COVID-19 Pandemic., Vineet M Arora, Charlie M Wray, Avital Y O'Glasser, Mark Shapiro, and Shikha Jain

Link

A heart-team hybrid approach for atrial fibrillation: a single-centre long-term clinical outcome cohort study., Gansevoort H Dunnington, Carrie L Pierce, Susan Eisenberg, Liem L Bing, Peter Chang-Sing, Daniel W Kaiser, Shelby Burk, Linda C Moulton, and Armin Kiankhooy

Link

Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study., Jarrod P Holmes, Julio A Peguero, R Campbell Garland, Janine North, Stacia Young, Lonnie D Brent, and Nancy Joseph-Ridge

Link

Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study., Jarrod P Holmes, Julio A Peguero, R Campbell Garland, Janine North, Stacia Young, Lonnie D Brent, and Nancy Joseph-Ridge

PDF

The TIME Trial® Network facilitates rapid clinical trial activation, patient screening, and enrollment in molecularly targeted trials, Stephanie O'Leary, Megan Shulman, Kevin Ritt, Meghan Degele, Ewelina Protomastro, Jennifer Clauson, Amy Franzen, Ian Churchill Anderson, Minal A. Barve, David N. Oubre, Victor Priego, Angela Saverimuthu, Francis Mark Senecal, Raju Kumar Vaddepally, Kimberly L. Blackwell, and Matthew M. Cooney

Link

Open-label, phase II study of ladiratuzumab vedotin (LV) for castration-resistant prostate cancer (SGNLVA-005, trial-in-progress)., Amna Falak Sher, Justine Yang Bruce, Nashat Y. Gabrail, Ian Churchill Anderson, Anna Patrikidou, Rachel E Sanborn, Jae Yong Cho, Arielle Shebay Lee, Jong-Seok Lee, Louise M. Nott, Do-Youn Oh, Sang Cheul Oh, Sung Yong Oh, Yinghui Wang, Zejing Wang, and Troy H. Guthrie

Submissions from 2020

Link

SCAI expert consensus statement on out of hospital cardiac arrest., Amir Lotfi, Lloyd W Klein, Ravi S Hira, Jaya Mallidi, Roxana Mehran, John C Messenger, Duane S Pinto, Michael R Mooney, Tanveer Rab, Demetri Yannopoulos, and Sean van Diepen